{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:11:08Z","timestamp":1788873068347,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008792","name":"Novartis Pharma GmbH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ahj.2026.107549","type":"journal-article","created":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T19:07:16Z","timestamp":1785697636000},"page":"107549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Impact of estimated total blood volume on NT-proBNP response to angiotensin receptor\u2013neprilysin inhibition in acute heart failure: Insights from the PREMIER study"],"prefix":"10.1016","volume":"302","author":[{"given":"Kazutaka","family":"Nogi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3352-7661","authenticated-orcid":false,"given":"Atsushi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunichi","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Kamishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Obokata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Kida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Matsue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Izawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shungo","family":"Hikoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Node","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2026.107549_bib0001","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","volume":"118","author":"Savarese","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ahj.2026.107549_bib0002","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41569-024-01046-6","article-title":"Global epidemiology of heart failure","volume":"21","author":"Khan","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ahj.2026.107549_bib0003","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107549_bib0004","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107549_bib0005","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA Guideline for the management of Heart Failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2026.107549_bib0006","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1253\/circj.CJ-25-0214","article-title":"Diagnostic approaches to heart failure with preserved ejection fraction (HFpEF) - identification of unrecognized HFpEF","volume":"89","author":"Okuno","year":"2025","journal-title":"Circ J"},{"key":"10.1016\/j.ahj.2026.107549_bib0007","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1093\/eurheartj\/ehae561","article-title":"In-hospital initiation of angiotensin receptor-neprilysin inhibition in acute heart failure: the PREMIER trial","volume":"45","author":"Tanaka","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2026.107549_bib0008","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.010906","article-title":"Comparison of blood volume profiles in heart failure with preserved and reduced ejection fractions: sex makes a difference","volume":"17","author":"Miller","year":"2024","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ahj.2026.107549_bib0009","doi-asserted-by":"crossref","first-page":"H1074","DOI":"10.1152\/ajpheart.00336.2021","article-title":"Blood volume expansion, normovolemia, and clinical outcomes in chronic human heart failure: more is better","volume":"321","author":"Miller","year":"2021","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.ahj.2026.107549_bib0010","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2026.107549_bib0011","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA Guideline for the management of Heart Failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Writing Committee","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2026.107549_bib0012","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1253\/circj.CJ-25-0002","article-title":"JCS\/JHFS 2025 guideline on diagnosis and treatment of heart failure","volume":"89","author":"Kitai","year":"2025","journal-title":"Circ J"},{"key":"10.1016\/j.ahj.2026.107549_bib0013","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1253\/circrep.CR-25-0029","article-title":"Prognostic impact of sustained reduction of N-terminal pro-B-type natriuretic peptide after initiating sacubitril\/valsartan - insights from the REVIEW-HF registry","volume":"7","author":"Takigami","year":"2025","journal-title":"Circ Rep"},{"key":"10.1016\/j.ahj.2026.107549_bib0014","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.amjcard.2004.01.070","article-title":"Relation of unrecognized hypervolemia in chronic heart failure to clinical status, hemodynamics, and patient outcomes","volume":"93","author":"Androne","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2026.107549_bib0015","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00392-020-01794-8","article-title":"Estimated plasma volume status in heart failure: clinical implications and future directions","volume":"110","author":"Kobayashi","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.ahj.2026.107549_bib0016","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/ejhf.2664","article-title":"Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology","volume":"24","author":"Nunez","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ahj.2026.107549_bib0017","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1253\/circj.CJ-19-0342","article-title":"JCS 2017\/JHFS 2017 guideline on diagnosis and treatment of acute and chronic heart failure- Digest version","volume":"83","author":"Tsutsui","year":"2019","journal-title":"Circ J"},{"key":"10.1016\/j.ahj.2026.107549_bib0018","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.cardfail.2021.04.023","article-title":"JCS\/JHFS 2021 guideline focused update on diagnosis and treatment of acute and chronic heart failure","volume":"27","author":"Tsutsui","year":"2021","journal-title":"J Card Fail"},{"key":"10.1016\/j.ahj.2026.107549_bib0019","first-page":"224","article-title":"Prediction of blood volume in normal human adults","volume":"51","author":"Nadler","year":"1962","journal-title":"Surgery"},{"key":"10.1016\/j.ahj.2026.107549_bib0020","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMoa1812851","article-title":"Angiotensin-neprilysin inhibition in acute decompensated heart failure","volume":"380","author":"Velazquez","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107549_bib0021","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.cardfail.2020.09.478","article-title":"Plasma volume status and its association with In-hospital and postdischarge outcomes in decompensated heart failure","volume":"27","author":"Fudim","year":"2021","journal-title":"J Card Fail"},{"key":"10.1016\/j.ahj.2026.107549_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.906272","article-title":"Endothelial dysfunction in heart failure with preserved ejection fraction: what are the experimental proofs?","volume":"13","author":"Cornuault","year":"2022","journal-title":"Front Physiol"},{"key":"10.1016\/j.ahj.2026.107549_bib0023","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1093\/eurheartj\/ehy531","article-title":"Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF","volume":"39","author":"Shah","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2026.107549_bib0024","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jchf.2024.12.010","article-title":"Effects of Sacubitril\/Valsartan according to natriuretic peptide levels in patients enrolled in PARADIGM-HF and PARAGON-HF","volume":"13","author":"Kondo","year":"2025","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.ahj.2026.107549_bib0025","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/HYPERTENSIONAHA.116.08484","article-title":"Effects of Sacubitril\/Valsartan (LCZ696) on natriuresis, diuresis, blood pressures, and NT-proBNP in salt-sensitive hypertension","volume":"69","author":"Wang","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2026.107549_bib0026","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jacbts.2022.05.010","article-title":"Neprilysin inhibitors in heart failure: the science, mechanism of action, clinical studies, and unanswered questions","volume":"8","author":"Bozkurt","year":"2023","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.ahj.2026.107549_bib0027","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jchf.2020.05.012","article-title":"NT-proBNP response to Sacubitril\/Valsartan in hospitalized heart failure patients with reduced ejection fraction: TRANSITION study","volume":"8","author":"Pascual-Figal","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.ahj.2026.107549_bib0028","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14228147","article-title":"Assessing venous congestion in acute and chronic heart failure: a review of splanchnic, cardiac and pulmonary ultrasound: part 1: conventional B-mode, colordoppler, and Vexus protocol","volume":"14","author":"Giangregorio","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.ahj.2026.107549_bib0029","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/ehf2.13739","article-title":"Discordance between estimated and measured changes in plasma volume among patients with acute heart failure","volume":"9","author":"Swolinsky","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.ahj.2026.107549_bib0030","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1002\/ejhf.70037","article-title":"Distinct blood volume and left ventricular adaptation to severe obesity in middle-aged adults at risk for heart failure","volume":"27","author":"Campain","year":"2025","journal-title":"Eur J Heart Fail"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870326002115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870326002115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:52:13Z","timestamp":1788871933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870326002115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":30,"alternative-id":["S0002870326002115"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2026.107549","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of estimated total blood volume on NT-proBNP response to angiotensin receptor\u2013neprilysin inhibition in acute heart failure: Insights from the PREMIER study","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2026.107549","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107549"}}